← Open Payments lookup

NADEZHDA DAVIS: Open Payments

NPI 1033269188 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,675 in 65 payments from 8 companies in 2025. Trend: 2023 $2,347 · 2024 $1,586 · 2025 $1,675

Food & beverage: $1,670Education: $5
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$461
Janssen Pharmaceuticals, Inc12$334
Teva Pharmaceuticals USA, Inc.8$258
E.R. Squibb & Sons, L.L.C.9$230
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$171
Otsuka America Pharmaceutical, Inc.4$86
Alkermes, Inc.3$68
Lundbeck LLC3$67

Products named: INGREZZA, INVEGA SUSTENNA, UZEDY, CAPLYTA, COBENFY, ARISTADA, REXULTI, ABILIFY ASIMTUFII.

Industry payments across CA — which companies pay providers there.